PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW146773View Pathway |
drug action
Benzylparaben Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 19:00 Last Updated: October 07, 2023 at 19:00 |
PW144788View Pathway |
drug action
Benzyl benzoate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:26 Last Updated: October 07, 2023 at 14:26 |
PW145779View Pathway |
drug action
Benzyl alcohol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:38 Last Updated: October 07, 2023 at 16:38 |
PW145964View Pathway |
drug action
Benzydamine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:04 Last Updated: October 07, 2023 at 17:04 |
PW176191View Pathway |
Benzthiazide Predicted Metabolism PathwayHomo sapiens
Metabolites of Benzthiazide are predicted with biotransformer.
|
Creator: Omolola Created On: December 04, 2023 at 12:30 Last Updated: December 04, 2023 at 12:30 |
PW144679View Pathway |
drug action
Benzthiazide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:11 Last Updated: October 07, 2023 at 14:11 |
PW127961View Pathway |
drug action
Benzthiazide Action PathwayHomo sapiens
Benzthiazide is a diuretic that acts by promoting water loss from the body. This drug is used in the treatment of hypertension and edema. They act on the kidneys by inhibiting the sodium-chloride reabsorption (via the Na+/Cl- cotransporter) from its early distal tubules. This inhibition of the cotransporter results in the increased excretion of sodium, chloride, and, in consequence, water. At the same time, it inhibits sodium transport across the renal tubular epithelium (by binding the Na+/Cl- cotransporter). In consequence, this will increase potassium excretion via the sodium-potassium exchange mechanism. The exact name of the inhibited transporter is the solute carrier family 12 member 3. The antihypertensive function of the drug is not well defined, but it is thought to act by the drug inhibition on the carbonic anhydrase or on the large-conductance calcium-activated potassium (kCa) channel, in the smooth muscles. An overdose of benzthiazide would result in symptoms like nausea, vomiting, drowsiness, and urinary problems. This drug is administered as an oral tablet.
|
Creator: Daphnee Created On: June 22, 2023 at 13:35 Last Updated: June 22, 2023 at 13:35 |
PW176754View Pathway |
drug action
Benzquinamide H1-Antihistamine Blood Vessel Constriction Action PathwayHomo sapiens
Benzquinamide is a discontinued antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors.
|
Creator: Ray Kruger Created On: December 19, 2023 at 14:16 Last Updated: December 19, 2023 at 14:16 |
PW176661View Pathway |
drug action
Benzquinamide H1 Antihistamine Smooth Muscle Relaxation Action PathwayHomo sapiens
Benzquinamide is a discontinued antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors.
H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria. H1-antihistamines act on H1 receptors in T-cells to inhibit the immune response, in blood vessels to constrict dilated blood vessels, and in smooth muscles of lungs and intestines to relax those muscles. Allergies causes blood vessel dilation which causes swelling (edema) and fluid leakage. Benzquinamide also inhibits the H1 histamine receptor on bronchiole smooth muscle myocytes. This normally activates the Gq signalling cascade which activates phospholipase C which catalyzes the production of Inositol 1,4,5-trisphosphate (IP3) and Diacylglycerol (DAG). Because of the inhibition, IP3 doesn't activate the release of calcium from the sarcoplasmic reticulum, and DAG doesn't activate the release of calcium into the cytosol of the endothelial cell. This causes a low concentration of calcium in the cytosol, and it, therefore, cannot bind to calmodulin. Calcium bound calmodulin is required for the activation of myosin light chain kinase. This prevents the phosphorylation of myosin light chain 3, causing an accumulation of myosin light chain 3. This causes muscle relaxation, opening up the bronchioles in the lungs, making breathing easier.
|
Creator: Ray Kruger Created On: December 19, 2023 at 13:10 Last Updated: December 19, 2023 at 13:10 |
PW144969View Pathway |
drug action
Benzphetamine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:49 Last Updated: October 07, 2023 at 14:49 |